SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
scPharmaceuticals Inc., a subsidiary of MannKind Corporation, announced Thursday the FDA approved FUROSCIX (furosemide injection 80 mg/10 mL) for subc...
**CARBIDOPA AND LEVODOPA** tablets have received FDA approval through the **Advagen Pharma Ltd.** ANDA, a move expected to intensify price competition...
Mallinckrodt Hospital Products Inc. announced FDA approval of the intravenous drug TERLIPRESSIN (Generic: TERLIPRESSIN), a significant milestone for t...
Zydus Pharmaceuticals USA Inc. announced on Tuesday the FDA approval of a generic version of global immunomodulatory drug manufacturer Johnson & Johns...
The FDA has granted approval to Squibb’s oral drug SOTYKTU (deucravacitinib) for the treatment of moderate-to-severe plaque psoriasis, a development t...
Novadoz Pharmaceuticals LLC has secured FDA approval for its generic Vigabatrin oral formulation, positioning the company to capitalize on cost-saving...
# FDA Approves Generic LENALIDOMIDE; Exelan Pharmaceuticals Enters High-Value Oncology Market Exelan Pharmaceuticals Inc. received FDA approval for i...
# FDA Approves ANDA for MSN The FDA has approved ANDA 211135 for MSN as of September 1, 2022, potentially expanding the company's portfolio in the ge...
# FDA Approves Generic Lenalidomide from Alvogen Alvogen, Inc. has received FDA approval for generic lenalidomide, an oral immunomodulatory drug used...
# FDA Approves Mylan's Generic Lenalidomide Mylan Pharmaceuticals Inc. received FDA approval for generic lenalidomide, a significant immunomodulatory...
Apotex Corp. received the FDA approval for its generic Lenalidomide on Aug. 30, expanding its portfolio to challenge competitors within the myeloma tr...
Hikma Pharmaceuticals USA Inc. received FDA approval for its generic oral version of Vigabatrin in August, a move expected to bolster the company's an...
Northstar Rx LLC has received FDA approval for IV pantoprazole sodium (ANDA 215860), a significant move that promises to bolster the availability of a...
# FDA Approves Axsome Therapeutics' AUVELITY for Major Depressive Disorder Axsome Therapeutics received FDA approval for AUVELITY (dextromethorphan h...
Advagen Pharma Limited received FDA approval on August 18, 2022, for the Abbreviated New Drug Application ANDA215724, finalizing its launch of the ora...
Building Distribution: Is Siyata's Group Of Strategic Business Collaborators Ready To Impact The Push-To-Talk Market?...
# FDA Approves AstraZeneca's CALQUENCE (acalabrutinib) AstraZeneca Pharmaceuticals LP received FDA approval for CALQUENCE (acalabrutinib), an oral B...
Is Siyata Mobile Walkie-ing The Talk-ie? Connecting People Around The World Via Next-Gen Mission-Critical Devices...
AbbVie announced the FDA approval of risankizumab-RZAA (Skyrizi) for intravenous use, a formulation that may broaden the biologic’s market presence al...
Are New Communication Products Like The SD7 Poised To Give A Significant Boost To The Push-To-Talk Market?...